SS Innovations Subsidiary Graduates First Cardiac Robotic Surgery Training Class, Expanding Global Reach

SS Innovations International, Inc. (NASDAQ: SSII) announced that its subsidiary, the SS International Centre for Robotics Surgery (SSICRS), has graduated the inaugural class of its Cardiac Robotic Surgery Training program. The five-day course brought together 33 participants from seven countries and 16 international faculty members for classroom instruction, live surgical demonstrations and hands-on training using the company’s SSi Mantra surgical robotic system.

The graduation of this first class is significant because it demonstrates the company's ability to train surgeons from around the world in robotic-assisted cardiac surgery, potentially accelerating the adoption of its technology. By providing comprehensive education, SS Innovations aims to make robotic surgery more accessible, particularly in regions where such advanced techniques are not widely available.

SS Innovations said SSICRS plans to expand its educational offerings through additional condensed training programs covering multiple surgical specialties, including urology, gynecology, thoracic, colorectal, gastrointestinal and general surgery. This expansion indicates the company's strategy to leverage its training center as a hub for surgical education, which could drive demand for its SSi Mantra system and associated instruments.

The company said the training center combines modern lecture facilities, advanced simulation labs, tele-proctoring and online learning modules to support surgeon education and the broader adoption of robotic-assisted surgery. The inclusion of tele-proctoring and online modules suggests that SS Innovations is building a scalable training model that can reach surgeons beyond those who can attend in person, potentially increasing its global footprint.

For investors, this development underscores SS Innovations' commitment to building an ecosystem around its surgical robotic platform, which could lead to increased sales and market penetration. The company's focus on affordability and accessibility positions it to compete in emerging markets where cost is a critical factor.

To view the full press release, visit https://ibn.fm/7oFgo.

About SS Innovations: SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.